Epidemiological Landscape of Cervical Cancer in Latin America (EVITA LATAM)

Latin American Cooperative Oncology Group (LACOG)

Status: Active, not recruiting

Conditions: Uterine Cervical Neoplasms

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT04947605

LACOG 0820

Details and patient eligibility

About

A portrait of clinical and epidemiological aspects of cervical cancer in Latin America is required to understand the high frequency of cervical cancer despite the existence of effective preventive tools. A better understanding of the current situation of this scenario will provide a valuable groundwork for the development of national and cooperative programs to improve cervical cancer prevention and treatment.

Enrollment: 524 patients

Sex: Female

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Women > 18 years.
• Histologically proven cervical carcinoma
• Diagnosis of carcinoma of the cervix since January 2018 or newly diagnosis or recurrent disease during the period of study recruitment.
• Any histology of cervical cancer at time of diagnosis.
• FIGO stage IB2-IVA
• Have available and adequate medical records for data collection
• Accept to participate in the project and sign the informed consent (if applicable)

Exclusion criteria

• FIGO stage I and IB1
• Non-invasive cervical cancer
• Synchronous tumor or second primary tumor in the last five years (exception for thyroid cancer or skin cancer non melanoma)